Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 3075 of 3284 entries
View as:

Evaluation of an Orally Administered Medication When Taken in Conjunction With Pramlintide

Phase: N/A Priority: Normal
NCT ID: NCT00044707 Org: User:
Start: 08/31/02 End: 09/30/02 Due: 09/30/03

Real-world Study on Dapagliflozin Usage in Patients With Heart Failure (HF) in Germany

Phase: N/A Priority: Normal
NCT ID: NCT06336330 Org: User:
Start: 04/25/24 End: 09/30/26 Due: 09/30/27

A Multi-center, Non-interventional, Prospective Study of Durvalumab in Unresectable Locally Advanced NSCLC in Routine Clinical Practice in Russia

Phase: N/A Priority: Normal
NCT ID: NCT05456867 Org: User:
Start: 05/31/22 End: 11/30/26 Due: 11/30/27

Study of Capivasertib in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT05008055 Org: User:
Start: 11/03/21 End: 10/25/24 Due: 10/25/25

BE Study Between a Capsule and a Sachet Formulation of D961H by Pharmacodynamics in Japanese Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01964131 Org: User:
Start: 10/31/13 End: 12/31/13 Due: 12/31/14

Study to Assess Functionality, Reliability, and Performance of a Pre-filled Syringe With Benralizumab Administered at Home

Phase: N/A Priority: Normal
NCT ID: NCT02417961 Org: User:
Start: 04/27/15 End: 03/14/16 Due: 03/14/17

Two-part Pharmacokinetic and Pharmacodynamic Study of LAS190792 in Patients With Asthma and COPD

Phase: N/A Priority: Normal
NCT ID: NCT02059434 Org: User:
Start: 09/01/13 End: 10/06/14 Due: 10/06/15

A Study to Examine the Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00112021 Org: User:
Start: 05/31/05 End: 11/30/05 Due: 11/30/06

Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke

Phase: N/A Priority: Normal
NCT ID: NCT00061022 Org: User:
Start: 05/31/03 End: 09/30/06 Due: 09/30/07

Study to Assess the Bioequivalence of Acalabrutinib Tablet and Acalabrutinib Capsule

Phase: N/A Priority: Normal
NCT ID: NCT04768985 Org: User:
Start: 02/25/21 End: 05/10/21 Due: 05/10/22

Safety Study to Explore Combination of Gefitinib (ZD1839, Iressa) and Radiotherapy in Non-Metastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00239291 Org: User:
Start: 01/31/03 End: 05/31/06 Due: 05/31/07

Mass Balance Recovery, Pharmacokinetics and Metabolite Profile and Identification of [14C]AZD7594

Phase: N/A Priority: Normal
NCT ID: NCT04002427 Org: User:
Start: 06/11/19 End: 07/05/19 Due: 07/05/20

Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Durvalumab

Phase: N/A Priority: Normal
NCT ID: NCT05303532 Org: User:
Start: 04/19/22 End: 01/07/26 Due: 01/07/27

Evaluating the Symbicort Turbuhaler (Formoterol/Budesonide) Maintenance and Reliever Therapy for Asthma in Daily Practice

Phase: N/A Priority: Normal
NCT ID: NCT00782314 Org: User:
Start: 04/30/08 End: 04/30/09 Due: 04/30/10

Phase II Iressa + Irradiation Followed by Chemo in NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT00333294 Org: User:
Start: 09/30/04 End: 01/31/06 Due: 01/31/07

A Study to Assess the Safety and Effect of TC-5214 in Patients With Major Depressive Disorder.

Phase: N/A Priority: Normal
NCT ID: NCT01288079 Org: User:
Start: 02/28/11 End: 08/31/12 Due: 08/31/13

LUMINIST: LUng Cancer Molecular Insights Non Interventional Study

Phase: N/A Priority: Normal
NCT ID: NCT02300831 Org: User:
Start: 12/01/14 End: 06/30/16 Due: 06/30/17

Prevention of Cardiovascular Events by Antiplatelet Agents After Acute Coronary Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01952392 Org: User:
Start: 10/31/13 End: 03/31/16 Due: 03/31/17

Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis

Phase: N/A Priority: Normal
NCT ID: NCT02174627 Org: User:
Start: 06/26/14 End: 10/04/18 Due: 10/04/19

A Study to Assess the Effect of AZD5462 on the Pharmacokinetics of Midazolam, Rosuvastatin and Digoxin

Phase: N/A Priority: Normal
NCT ID: NCT05395117 Org: User:
Start: 06/30/22 End: 09/12/22 Due: 09/12/23

Symptom Improvements in Gastroesophageal Reflux Disease (GERD) Patients

Phase: N/A Priority: Normal
NCT ID: NCT00394472 Org: User:
Start: 11/30/06 End: 06/30/07 Due: 06/30/08

Efficacy and Tolerability Study in Severe Chronic Obstructive Pulmonary Disease (COPD) Patients

Phase: N/A Priority: Normal
NCT ID: NCT01415518 Org: User:
Start: 09/01/11 End: 12/01/12 Due: 12/01/13

Study to Investigate the Analgesic Efficacy of a Single Dose of AZD1386

Phase: N/A Priority: Normal
NCT ID: NCT00672646 Org: User:
Start: 04/30/08 End: 06/30/08 Due: 06/30/09

SYMPHONIE - A Comparison of Symbicort Single Inhaler and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and Adults

Phase: N/A Priority: Normal
NCT ID: NCT00259792 Org: User:
Start: 09/30/04 End: 01/31/06 Due: 01/31/07

A Study to Assess the Safety, Tolerability and Pharmacokinetics of Modified-Release Formulations of AZD1446 After Oral Single and Repeated Doses

Phase: N/A Priority: Normal
NCT ID: NCT01199315 Org: User:
Start: 09/30/10 End: 12/31/10 Due: 12/31/11